Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.411, 2003-01, pp. : 7-7
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Cost effectiveness of celecoxib, rofecoxib in OA and RA
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 352, 2002-01 ,pp. :
Access to resources
Recommend
Cost effectiveness of celecoxib, rofecoxib in OA and RA
Inpharma, Vol. 1, Iss. 1327, 2002-01 ,pp. :
Celecoxib: low cost alternative in OA and RA
Inpharma, Vol. 1, Iss. 1278, 2001-01 ,pp. :
CV events account for large cost burden in hypertension
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 408-409, 2003-01 ,pp. :
Celecoxib: a model therapy for RA and OA
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 277, 2000-01 ,pp. :